Resuming Anticoagulation After High Bleeding Risk Surgery

Risk Classification and Timing

Anterior cervical fusion is considered a high bleeding risk procedure due to proximity to vital neurovascular structures and potential for catastrophic consequences if bleeding occurs 1, 2
For patients with impaired renal function, a longer discontinuation period of anticoagulation may be necessary before surgery 1, 2

The American Society of Regional Anesthesia and Pain Medicine recommends resuming apixaban 2-3 days (48-72 hours) after high bleeding risk surgery, including anterior cervical fusion, once adequate hemostasis has been established 3, 4
No bridging anticoagulation is typically required during the 48-72 hour window after surgery 2, 5

For patients at high risk of thromboembolism, consider starting with a reduced dose of apixaban (2.5 mg twice daily) for the first 1-2 days after surgery 3, 4
For standard risk patients, resume the regular therapeutic dose of apixaban (5 mg twice daily for most patients) after the 48-72 hour waiting period 3, 4

Resuming full-dose anticoagulation too early (less than 48 hours) after surgery increases bleeding risk, as recommended by the European Society of Anaesthesiology 3, 2
Delaying anticoagulation for too long in high-risk thrombotic patients can increase the risk of thrombotic events, according to the European Society of Cardiology 6
Not communicating the anticoagulation resumption plan clearly between surgical and medical teams can lead to errors, as noted by the American Society of Anesthesiologists 2

The American College of Chest Physicians recommends resuming anticoagulation at least 24 hours after surgery, with the exact timing dependent on the bleeding risk of the procedure 7
For patients undergoing low bleeding risk procedures, Eliquis should be restarted 24 hours after surgery at the regular dose, typically 5 mg twice daily for most patients 8
For patients undergoing high bleeding risk procedures, Eliquis should be restarted 48-72 hours after surgery once adequate hemostasis has been established, with consideration of a reduced dose for the first 1-2 days after surgery for those at high risk of thromboembolism 8

When determining the exact timing of resumption, balance the risk of bleeding against the risk of thromboembolism, considering patient-specific factors such as renal function and thrombotic risk 7

Monitor for signs of bleeding after resuming anticoagulation, as recommended by the American College of Chest Physicians 7